Akero Therapeutics (AKRO) had the highest return between August 1, 2022 and December 30, 2022 by a mid-cap US stock, returning 427.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 8/1/2022 - 12/30/2022 | 427.43% |
Madrigal Pharmaceuticals (MDGL) | 8/1/2022 - 12/30/2022 | 364.77% |
Verona Pharma PLC ADR (VRNA) | 8/1/2022 - 12/30/2022 | 360.85% |
Immunovant (IMVT) | 8/1/2022 - 12/30/2022 | 338.27% |
Viking Therapeutics (VKTX) | 8/1/2022 - 12/30/2022 | 215.44% |
Rhythm Pharmaceuticals (RYTM) | 8/1/2022 - 12/30/2022 | 133.9% |
Weatherford International (WFRD) | 8/1/2022 - 12/30/2022 | 125.31% |
Melco Resorts & Entertainment (MLCO) | 8/1/2022 - 12/30/2022 | 124.17% |
Vaxcyte (PCVX) | 8/1/2022 - 12/30/2022 | 110.12% |
Manchester United (MANU) | 8/1/2022 - 12/30/2022 | 109.8% |
Nuvalent (NUVL) | 8/1/2022 - 12/30/2022 | 104.39% |
Turkcell Iletisim Hizmetleri AS (TKC) | 8/1/2022 - 12/30/2022 | 102.96% |
Roivant Sciences (ROIV) | 8/1/2022 - 12/30/2022 | 101.77% |
Axsome Therapeutics (AXSM) | 8/1/2022 - 12/30/2022 | 100.6% |
F&G Annuities & Life (FG) | 8/1/2022 - 12/30/2022 | 100.1% |
TG Therapeutics (TGTX) | 8/1/2022 - 12/30/2022 | 99.49% |
Transportadora de Gas del Sur SA ADR (TGS) | 8/1/2022 - 12/30/2022 | 97.32% |
Torm PLC Class A (TRMD) | 8/1/2022 - 12/30/2022 | 90.57% |
Miniso Group Holding (MNSO) | 8/1/2022 - 12/30/2022 | 88.03% |
Catalyst Pharmaceuticals (CPRX) | 8/1/2022 - 12/30/2022 | 82.35% |
ADMA Biologics (ADMA) | 8/1/2022 - 12/30/2022 | 82.16% |
Vista Oil Gas ADR (VIST) | 8/1/2022 - 12/30/2022 | 78.36% |
Tidewater (TDW) | 8/1/2022 - 12/30/2022 | 71.88% |
MoonLake Immunotherapeutics (MLTX) | 8/1/2022 - 12/30/2022 | 69.9% |
Oceaneering International (OII) | 8/1/2022 - 12/30/2022 | 69.81% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
